Detailed information for compound 902857

Basic information

Technical information
  • TDR Targets ID: 902857
  • Name: N'-(4-bromo-2-methylphenyl)-N-[(4-fluoropheny l)methyl]oxamide
  • MW: 365.197 | Formula: C16H14BrFN2O2
  • H donors: 2 H acceptors: 2 LogP: 3.46 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)CNC(=O)C(=O)Nc1ccc(cc1C)Br
  • InChi: 1S/C16H14BrFN2O2/c1-10-8-12(17)4-7-14(10)20-16(22)15(21)19-9-11-2-5-13(18)6-3-11/h2-8H,9H2,1H3,(H,19,21)(H,20,22)
  • InChiKey: USZDTJLWEUNYOL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N'-(4-bromo-2-methyl-phenyl)-N-[(4-fluorophenyl)methyl]oxamide
  • N'-(4-bromo-2-methyl-phenyl)-N-(4-fluorobenzyl)oxamide
  • N'-(4-bromo-2-methyl-phenyl)-N-[(4-fluorophenyl)methyl]ethanediamide
  • ZINC04858188

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi PAB1-binding protein , putative 0.0023 0.0866 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.0023 0.0866 0.5
Echinococcus granulosus tar DNA binding protein 0.0059 0.4565 1
Schistosoma mansoni tar DNA-binding protein 0.0059 0.4565 0.921
Brugia malayi Calcitonin receptor-like protein seb-1 0.009 0.7807 0.7807
Brugia malayi RNA binding protein 0.0059 0.4565 0.4565
Loa Loa (eye worm) hypothetical protein 0.0028 0.1391 0.0575
Brugia malayi Latrophilin receptor protein 2 0.0028 0.1391 0.1391
Toxoplasma gondii LsmAD domain-containing protein 0.0023 0.0866 0.5
Brugia malayi TAR-binding protein 0.0059 0.4565 0.4565
Plasmodium falciparum ataxin-2 like protein, putative 0.0023 0.0866 0.5
Loa Loa (eye worm) RNA binding protein 0.0059 0.4565 0.405
Echinococcus multilocularis tar DNA binding protein 0.0059 0.4565 1
Loa Loa (eye worm) transcription factor SMAD2 0.0111 1 1
Loa Loa (eye worm) hypothetical protein 0.009 0.7807 0.7599
Brugia malayi latrophilin 2 splice variant baaae 0.0061 0.4837 0.4837
Schistosoma mansoni tar DNA-binding protein 0.0059 0.4565 0.921
Loa Loa (eye worm) latrophilin receptor protein 2 0.0028 0.1391 0.0575
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0028 0.1391 0.1391
Schistosoma mansoni tar DNA-binding protein 0.0059 0.4565 0.921
Plasmodium vivax ataxin-2 like protein, putative 0.0023 0.0866 0.5
Brugia malayi hypothetical protein 0.0023 0.0866 0.0866
Schistosoma mansoni hypothetical protein 0.0061 0.4837 1
Brugia malayi RNA recognition motif domain containing protein 0.0059 0.4565 0.4565
Loa Loa (eye worm) MH2 domain-containing protein 0.0111 1 1
Loa Loa (eye worm) TAR-binding protein 0.0059 0.4565 0.405
Plasmodium falciparum ataxin-2 like protein, putative 0.0023 0.0866 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.009 0.7807 0.7599
Schistosoma mansoni tar DNA-binding protein 0.0059 0.4565 0.921
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.009 0.7807 0.7807
Trypanosoma cruzi PAB1-binding protein , putative 0.0023 0.0866 0.5
Loa Loa (eye worm) hypothetical protein 0.0061 0.4837 0.4348
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0059 0.4565 0.405
Schistosoma mansoni tar DNA-binding protein 0.0059 0.4565 0.921
Leishmania major hypothetical protein, conserved 0.0023 0.0866 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.